JFIFC    $ &%# #"(-90(*6+"#2D26;=@@@&0FKE>J9?@=C  =)#)==================================================" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?XȞ¥U) D~N>(ʗm?J1{v+\}:SHPE?4:SJ:Pi>CJ:R k^%4 -!w>=Oa? >ɘng֦ū]Mh ˖8#y熧r% )<~f4\u[=n]I3!"U O5eջn]#U Z# +; )>)}Jp_aҩGڍ(_.ߧJ`E۵'l}:Q9@ʘcV}:SJ})MuE*<})})}:St8JL}:RctcF>)}:RcS.}(t])@U˱W8^ղ>)ȌR0EKW*.3)\76%03Rkiw>%m&kPלmsZriGw}<0x3\VeiL{lqϖS޺ N`1cOһyaNǰGJ?&=J1:SKJbJ1c۵S{{ ~>)PE~TuE(JpNKtGҀ˥J?.~TO˥!:Rå'ҁzM?JR~*)+(p;݁+?A^i+ h/n.ާwWne=R=6A2=+5 Uޟ{]sjNAt`#ɥ FOA.;L9 '}CKL9M&ӜM.Bֶ"|)ּ+\{K1dTWp?"ƍ͎^?EP_åGQR])NJ?.tKtcҗN~]).L}:Q/ғHQJ (N;SGJӥHgҏ˥'KtQtPzvbMgTRI8MjuZy#ٹ~+ Pt.]]A`cѝXʣN1*Rv:K`VܠAިG1-4y=eW9n\N2SQ)2D1L\Ug>3y%c$8# ^:,J%l\Ad1%up;0$*kFpijs>^ZNsdzU2fUBQ<(NW$޺?xB_ ]@]C:$6dh]k6] &UvlWsv8yc>eb[n?t1]* G݈TUt84tJ?HC.JoҌ:PҗItLR~TåPOҊh(2"eֹ3\J3Nqi;~g:1:uY1 pAMc¥ɖtk W5X<ee'aTR *``MN)$~ue`JDzKzĈx*x^T津94ЛGZ<%8 齓ir*LJu{_2y9T9˂3%h٢xϣlI22bx6YziX儥GݑO  Kƌ&c-xR[ObwQI,׭ʶ +4NS2MIV*~e`ըF&GZ.cSGҢ)I@*_ʭ;/җG~(S~](QSJ)OEyslVܼ |3+ۯjRpr@1Ƈi܎kҞ !UWED1i7(`,:qkNO g7Һu 8]~o՜RO*V$MMZ@/5异. u -7p|ՍsXH !dGGpt88R^yOˮJ)!=ᾃX0JФ?F@Yqx` h$E( R_#[&`rM,NmkxK׮.J]J:46QHk]v`4CKKhKgO¢VUEiSc=k km+$N\:e-_GՍ.}CQ4\^FC䢣 ڡm/F—%ceBEGcJhǒj3Ĺs֓=FIDie+][?ȩ~xc_bȶ9 G{VxKe c 1D #0N_nƕ̹<c巶Ҧ-]`n<ל7wuӑrq]5;it:jN.|T(ی }reRH͋[=S эWKUke 3\UoxJAn nr}`ȤY d' _;OAIր^:uLZ/&2HgU7z=+MVԡVg8m"Lju%iri=B=y-dXb>26p>y/3z׈3<%u%.oo+d?ݿzWx",`9~=dW7cS+ wVRC#8Ym^<)YUOU'kë)!eV$*$Ċ)݁C{U$r ?/,6OQ:US9#E\%[ƧN1Pj2 4枡B6V8)kڥh| z[L2ʼnֲMh%dU+nLsɮh _W;=]BR֩$g̜nO¥'|-lGm F%i5h_WWIs* T'DF]yO&yB:fʲɝ)#ol Se٤mеĈ>$eT09=EJ[$u"PFBmF}=l@q9hU:ɣ*If+yȥJ嗑ߵApNF L>Tث>7Wr!8N"7\zL`s.4ܐH ǯ@LGu}Uc^As֓$lC) {НpI.}q3f5.N?}}*.t^9\\3e٥9 _%,2##(d;w HR‘KmJq#?]TIW1sYB`>\D7ey~"kQƃpqIcrQ$(Pj',# VxW4ddcOZY'G=?F2V1'@>1G\xAp)7DQpL3Z 4{Z)rͅ|&H\vR.@ϵIIJFcSS&ppGAP? EԂP$jKMEm`\c;cLThG$sIq+% ?Iϼ}<#k6p#u(\ PK;6v=M#֐[ٝLdTRPiof4D_өAyag ˧9L/֤zn$8F >.lRH-ߺSQ̀1^ r0~H⋦+7\.@=*n ~R!݁.~z QnǮ*+Ic9 ujKp#3=>s#yN1cH=JJ7nʄ8^pOOӇ=v*ϸKcTsL^8tVyIVVEVf'ui>v%̆I䐎Y$m++֞hWwO Sz gin؜ ~:|9 ? .go\O,՘I5V3=b%?/?7k$H5;ȡ Fp?JWᴺgTg4) 2y4#&J݀i xsMi)e87P-CTkpV>i2ZM/e$=i~Ѯ,mpv"+?%v@p~[N;BÒ+; {¶^VY1sm-C2u{Q^BX+98]!3Pt$l; .s8Ķ RcF(̋D#$59%T5ב(\ah^ţ}պ*d(d樯(۱8bN_4vàO)ϕ8ϽZ6uXGm?em&\ %X20RQB$('\|o&ӷyh"OyQ^)l\ڣr ]qJhT'fa7汶1?}+QnqV|Wg ַjϷ,$Lxh2Y$R1%'?JX5=ʲ,X`4g5@ΌꮲS5r?Daⷐy1vݏz xf%6rQ[ۚNwf|N1gNRkgx-`[ |SvV G'94G#B>\OS ȧ sޗh"E*>e?G?SVgg,}u_ I(qiW<8g8)TgV^~SOA/0|d@ %+MuFU.z 0J oBr}s֘{}i<ƍ!ӵG)jֱ%|.q<( U :Ss`Mg'I=5%d=hf*p8 6)9M#Q9 LJ_jF$dpGLvE>m\Z߽lҙ5H9'OVAT1Z0S(sR}jI>V֑yymF$9E"A?ҞQ`P8f(x1T}2G_+ހZjFFOSN'1DXxh('zQFN:?U'`9' Dc$sYjYdn''ɪ1&C%RmM[i&a}LZ%1%p@'եj(ơ| sRkl=S@4 aM (ܸNF.Y*Xּ* x>QZ"D*ܐ~ WTdp;!hA%ί}vi\1+k RӜvq>QRXUm&ݽ|ʡۥUΞ}8VAs!w)"9_@U) Q@iarrhea, nausea. None were reported. Not only has Kraemer thoroughly examined creatine, he also used it when he was a competitive athlete as did his 17-year-old daughter when she played high school tennis and his 15-year-old son when he was weight lifting. Again, no adverse side affects. Creatine does have one well-documented side effect. It causes an increase in muscle mass. When taken as prescribed it has the capacity to increase body weight by as much as seven pounds in five days.<br>Are there any long term effects? The long term effect of creatine has never been studied. However, creatine has been used in the past and without incident. Athletes in the 1940s and 1950s used it until steroids became available. They switched to steroids because they got results much faster. The Eskimos ingest up to four grams of creatine per day through their high consumption of meat and fish, twice that of Americans, and, have not had any documented ill effects.<br>How much time is considered long term? Is it 5 years, 10 years, or 50 years? The FDA has been studying creatine since it exploded onto the sports scene in 1992. Dr. Mike Stone from Appalachian State University, a leader in the field of Muscle Physiology, has been studying athletes who have bee taking creatine for as long as six years. To date, there are no reports of kidney, heart or liver problems.<br>Since there is no document